Itron (NASDAQ:ITRI) SVP Sells $373,772.70 in Stock

Itron, Inc. (NASDAQ:ITRI) SVP Laurie Ann Pulatie-Hahn sold 3,755 shares of Itron stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $99.54, for a total transaction of $373,772.70. Following the sale, the senior vice president owned 33,679 shares in the company, valued at approximately $3,352,407.66. This represents a 10.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Laurie Ann Pulatie-Hahn also recently made the following trade(s):

• On Friday, February 20th, Laurie Ann Pulatie-Hahn sold 729 shares of Itron stock. The shares were sold at an average price of $100.17, for a total transaction of $73,023.93.
• On Wednesday, February 11th, Laurie Ann Pulatie-Hahn sold 142 shares of Itron stock. The shares were sold at an average price of $105.26, for a total transaction of $14,946.92.

Itron Stock Down 0.7%

ITRI stock opened at $97.15 on Thursday. The firm’s 50-day moving average is $97.82 and its two-hundred day moving average is $109.44. The company has a market capitalization of $4.37 billion, a price-to-earnings ratio of 14.92, a price-to-earnings-growth ratio of 0.85 and a beta of 1.48. Itron, Inc. has a 52 week low of $88.57 and a 52 week high of $142.00. The company has a current ratio of 1.80, a quick ratio of 1.56 and a debt-to-equity ratio of 0.45.

Itron (NASDAQ:ITRI) last posted its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.19 by $0.27. Itron had a net margin of 12.72% and a return on equity of 20.04%. The business had revenue of $571.66 million during the quarter, compared to analysts’ expectations of $561.31 million. During the same period last year, the firm posted $1.35 earnings per share. The business’s revenue was down 6.7% on a year-over-year basis. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

Itron News Roundup

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Itron’s Q4 results and guidance surprised to the upside — the company reported an EPS beat and set Q1 and FY2026 EPS guidance that supports continued profitability, which is a constructive fundamental datapoint for valuation and near‑term earnings expectations. 5 Insightful Analyst Questions From Itron’s Q4 Earnings Call
• Neutral Sentiment: Itron priced an upsized $700M 0.00% convertible senior notes offering due 2032; proceeds will fund a $100M concurrent repurchase, capped‑call hedges, repayment of existing 2026 convertible notes and general corporate purposes. The structure (conversion price ≈ $123.77, capped call cap ≈ $190.42) reduces immediate cash interest but introduces conversion/dilution mechanics and near‑term hedging activity that may create volatility. Itron Prices Upsized $700.0 Million Convertible Senior Notes Offering
• Negative Sentiment: A concentrated cluster of insider stock sales by multiple senior executives (including the CFO and several SVPs) occurred around Feb. 19–20 at prices near $99–$100 — the volume and timing (many filings disclosed in the same window) can be read negatively by the market as increased supply or reduced insider conviction. Wave of Insider Moves as Itron’s Top Brass Cash In on Company Stock
• Negative Sentiment: Institutional rebalancing reported in recent datasets shows several large asset managers materially reducing ITRI positions in the latest quarter — such outflows from big holders can amplify downward pressure if sustained. Quiver Quant Summary (includes institutional and insider activity)

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ITRI shares. Stephens upgraded Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price objective for the company in a report on Monday, November 3rd. Weiss Ratings cut shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Oppenheimer upped their price target on shares of Itron from $125.00 to $133.00 and gave the company an “outperform” rating in a report on Wednesday, February 18th. Johnson Rice raised shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective on the stock in a research note on Monday, January 5th. Finally, Wall Street Zen downgraded shares of Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $138.56.

Institutional Investors Weigh In On Itron

Hedge funds have recently made changes to their positions in the company. Impax Asset Management Group plc grew its holdings in shares of Itron by 127.3% during the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after buying an additional 890,040 shares in the last quarter. Norges Bank acquired a new stake in Itron during the 4th quarter worth about $63,990,000. Soros Fund Management LLC purchased a new position in Itron during the 4th quarter valued at about $34,843,000. Millennium Management LLC increased its holdings in shares of Itron by 269.3% in the 4th quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock valued at $47,068,000 after purchasing an additional 369,617 shares during the period. Finally, Merewether Investment Management LP increased its holdings in shares of Itron by 1,552.7% in the 2nd quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock valued at $39,593,000 after purchasing an additional 282,587 shares during the period. Hedge funds and other institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.